Peer-reviewed publication in “The Oncologist” is now available onlineInvestigational same-day dosing of Rolvedon demonstrated a clinical response and adverse event profile similar to next-day ...
GLP-1 weight-loss pills appear to be just as effective as injections, with clinical trials showing similar average weight ...
Atacicept, a novel dual inhibitor of BAFF and APRIL, receives FDA Priority Review for IgA nephropathy treatment in adults.
With durable responses, encouraging survival outcomes, and evidence that some patients may become eligible for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback